US stock screener
Every US-listed company we cover, ranked by what it reported to the SEC. Figures come from each company’s own filings (P/E and dividend yield combine SEC share counts and TTM results with a daily price snapshot). Click a column to sort, or open a company for its full statements with per-figure provenance.
All sectorsTechnologyFinancialsHealthcareConsumer DiscretionaryConsumer StaplesEnergyIndustrialsMaterialsUtilitiesReal EstateCommunication Services
558 companies in Healthcare · page 3 of 6
| Company | Sector | Market cap | Revenue (FY) | Rev growth | Net margin | ROE | P/E (TTM) | Div yield |
|---|---|---|---|---|---|---|---|---|
| Autolus Therapeutics plc (AUTL) | Healthcare | $389.9M | $75.4M | 644.9% | — | -161.4% | — | — |
| CytomX Therapeutics, Inc. (CTMX) | Healthcare | $744.5M | $76.2M | -44.8% | -22.8% | -17.5% | — | — |
| Burning Rock Biotech Ltd (BNR) | Healthcare | $99.7M | $77.2M | 9.2% | -10.3% | -10.3% | — | — |
| Sight Sciences, Inc. (SGHT) | Healthcare | $255.7M | $77.4M | -3.1% | -49.7% | -60.1% | — | — |
| Eton Pharmaceuticals, Inc. (ETON) | Healthcare | $1.19B | $80.0M | 104.9% | -5.8% | -17.6% | — | — |
| TELA Bio, Inc. (TELA) | Healthcare | $31.8M | $80.3M | 15.8% | -48.4% | -615.1% | — | — |
| ADC Therapeutics SA (ADCT) | Healthcare | $161.5M | $81.4M | 14.9% | — | — | — | — |
| MeiraGTx Holdings plc (MGTX) | Healthcare | $1.13B | $81.4M | 144.6% | — | — | — | — |
| FITLIFE BRANDS, INC. (FTLF) | Healthcare | $96.4M | $81.5M | 26.4% | 7.8% | 14.5% | 60.4 | — |
| Arcturus Therapeutics Holdings Inc. (ARCT) | Healthcare | $170.3M | $82.0M | -46.1% | -80.2% | -30.7% | — | — |
| IRADIMED CORP (IRMD) | Healthcare | $1.20B | $83.8M | 14.4% | 26.8% | 23.8% | 51.4 | 1.3% |
| Nurix Therapeutics, Inc. (NRIX) | Healthcare | $2.45B | $84.0M | 54.0% | — | -49.1% | — | — |
| ARS Pharmaceuticals, Inc. (SPRY) | Healthcare | $595.8M | $84.3M | -5.5% | — | -149.9% | — | — |
| 4D Molecular Therapeutics, Inc. (FDMT) | Healthcare | $572.9M | $85.2M | 230194.6% | — | -27.7% | — | — |
| DELCATH SYSTEMS, INC. (DCTH) | Healthcare | $432.6M | $85.2M | 129.1% | 3.2% | 2.4% | 1253 | — |
| STANDARD BIOTOOLS INC. (LAB) | Healthcare | $320.4M | $85.3M | -6.2% | -87.8% | -17.7% | 4.1 | — |
| LakeShore Biopharma Co., Ltd. (LSBCF) | Healthcare | — | $85.7M | 6.0% | -16.3% | -20.0% | — | — |
| HARVARD BIOSCIENCE INC (HBIO) | Healthcare | $27.6M | $86.5M | -8.1% | -65.5% | -412.8% | — | — |
| CYTOKINETICS INC (CYTK) | Healthcare | $11.16B | $88.0M | 376.6% | — | — | — | — |
| BIODESIX INC (BDSX) | Healthcare | $218.9M | $88.5M | 24.1% | -39.8% | — | — | — |
| Ceribell, Inc. (CBLL) | Healthcare | $678.8M | $89.1M | 36.1% | -60.0% | -34.4% | — | — |
| VASO Corp (VASO) | Healthcare | $33.4M | $89.1M | 2.7% | 1.8% | 5.3% | 19.0 | — |
| Pulmonx Corp (LUNG) | Healthcare | $51.1M | $90.5M | 8.0% | -59.7% | -99.8% | — | — |
| SIGA TECHNOLOGIES INC (SIGA) | Healthcare | $225.9M | $94.6M | -31.8% | 24.6% | 11.7% | 11.7 | 19.2% |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Healthcare | $1.26B | $95.1M | 59.0% | — | -50.7% | — | — |
| BIOLIFE SOLUTIONS INC (BLFS) | Healthcare | $1.43B | $96.2M | 28.9% | -4.8% | -1.2% | — | — |
| Butterfly Network, Inc. (BFLY) | Healthcare | $1.78B | $97.6M | 19.0% | -79.0% | -39.3% | — | — |
| NeuroPace Inc (NPCE) | Healthcare | $497.1M | $100.0M | 25.1% | -21.5% | -112.8% | — | — |
| Beta Bionics, Inc. (BBNX) | Healthcare | $785.2M | $100.3M | 53.9% | -73.0% | -25.5% | — | — |
| SUTRO BIOPHARMA, INC. (STRO) | Healthcare | $391.1M | $102.5M | 65.2% | — | — | — | — |
| Sanara MedTech Inc. (SMTI) | Healthcare | $233.7M | $103.1M | 19.0% | -36.4% | -633.5% | — | — |
| Owlet, Inc. (OWLT) | Healthcare | $154.0M | $105.7M | 35.4% | -37.5% | — | — | — |
| Zymeworks Inc. (ZYME) | Healthcare | $1.70B | $106.0M | 38.9% | -76.6% | -30.2% | — | — |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | Healthcare | $740.1M | $106.5M | 350.9% | 78.2% | 53.8% | 6.3 | — |
| Theravance Biopharma, Inc. (TBPH) | Healthcare | $873.8M | $107.5M | 66.9% | 98.5% | 35.7% | 7.6 | — |
| MANNATECH INC (MTEX) | Healthcare | $8.5M | $108.0M | -8.3% | -14.1% | — | — | — |
| Century Therapeutics, Inc. (IPSC) | Healthcare | $387.8M | $109.2M | 1556.8% | -8.8% | -6.0% | — | — |
| UroGen Pharma Ltd. (URGN) | Healthcare | $2.07B | $109.8M | 21.4% | — | — | — | — |
| GEOSPACE TECHNOLOGIES CORP (GEOS) | Healthcare | $91.8M | $110.8M | -18.3% | -8.8% | -7.7% | — | — |
| Anika Therapeutics, Inc. (ANIK) | Healthcare | $201.7M | $112.8M | -5.9% | -9.6% | -7.6% | — | — |
| ImmunityBio, Inc. (IBRX) | Healthcare | $7.87B | $113.3M | 668.3% | — | — | — | — |
| AGENUS INC (AGEN) | Healthcare | $232.4M | $114.2M | 10.4% | -2.7% | — | 3.5 | — |
| ORASURE TECHNOLOGIES INC (OSUR) | Healthcare | $265.1M | $115.0M | -38.1% | -59.8% | -20.2% | — | — |
| GYRE THERAPEUTICS, INC. (GYRE) | Healthcare | $662.2M | $116.6M | 10.2% | 8.5% | 6.9% | — | — |
| Outset Medical, Inc. (OM) | Healthcare | $76.6M | $119.5M | 5.1% | -68.3% | -64.3% | — | — |
| Atara Biotherapeutics, Inc. (ATRA) | Healthcare | $77.8M | $120.8M | -6.3% | 27.1% | — | — | — |
| Monte Rosa Therapeutics, Inc. (GLUE) | Healthcare | $2.01B | $123.7M | 63.5% | -31.2% | -16.6% | — | — |
| Xencor Inc (XNCR) | Healthcare | $1.45B | $125.6M | 13.7% | -73.2% | -14.5% | — | — |
| LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | Healthcare | $171.8M | $128.9M | 0.5% | -30.0% | — | — | — |
| Niagen Bioscience, Inc. (NAGE) | Healthcare | $270.4M | $129.4M | 29.9% | 13.4% | 22.7% | 16.2 | — |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | Healthcare | $14.9M | $129.9M | 14.1% | -10.5% | -19.8% | — | — |
| Xtant Medical Holdings, Inc. (XTNT) | Healthcare | $60.3M | $133.9M | 14.2% | 3.7% | 9.8% | 43.0 | — |
| RxSight, Inc. (RXST) | Healthcare | $222.3M | $134.5M | -3.9% | -29.0% | -14.1% | — | — |
| NRC HEALTH (NRC) | Healthcare | $486.6M | $137.4M | -4.0% | 8.4% | 82.9% | — | 2.4% |
| Quanterix Corp (QTRX) | Healthcare | $184.7M | $138.9M | 1.1% | -77.1% | -36.2% | — | — |
| Beam Therapeutics Inc. (BEAM) | Healthcare | $2.83B | $139.7M | 120.0% | -57.2% | -6.5% | — | — |
| InfuSystem Holdings, Inc (INFU) | Healthcare | $179.6M | $143.4M | 6.4% | 4.6% | 11.6% | 24.1 | — |
| Karyopharm Therapeutics Inc. (KPTI) | Healthcare | $162.7M | $146.1M | 0.6% | — | — | — | — |
| Cronos Group Inc. (CRON) | Healthcare | $1.05B | $146.6M | 24.6% | -6.4% | -0.8% | 280 | — |
| GRAIL, Inc. (GRAL) | Healthcare | $3.03B | $147.2M | 17.2% | — | -15.8% | — | — |
| ELITE PHARMACEUTICALS INC /NV/ (ELTP) | Healthcare | $398.5M | $148.9M | 77.1% | 30.1% | 45.4% | — | — |
| Neuronetics, Inc. (STIM) | Healthcare | $130.8M | $149.2M | 99.2% | -26.1% | -148.6% | — | — |
| MACROGENICS INC (MGNX) | Healthcare | $273.3M | $149.5M | -0.3% | -49.9% | -134.2% | — | — |
| Airsculpt Technologies, Inc. (AIRS) | Healthcare | $342.9M | $151.8M | -15.8% | -7.7% | -13.3% | — | — |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | Healthcare | $88.5M | $154.9M | 7.4% | -13.0% | -140.9% | — | — |
| Liquidia Corp (LQDA) | Healthcare | $7.74B | $158.3M | 1031.2% | -43.5% | -154.0% | 544 | — |
| MARIMED INC. (MRMD) | Healthcare | $26.0M | $159.8M | 1.3% | -9.1% | — | — | — |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Healthcare | $428.6M | $160.0M | 3.9% | — | -10214.5% | — | — |
| Ginkgo Bioworks Holdings, Inc. (DNA) | Healthcare | $493.2M | $170.2M | -25.1% | — | -61.5% | — | — |
| REGENXBIO Inc. (RGNX) | Healthcare | $656.2M | $170.4M | 104.5% | — | -188.7% | — | — |
| Syndax Pharmaceuticals Inc (SNDX) | Healthcare | $1.88B | $172.4M | 627.8% | — | -441.6% | — | — |
| SBC Medical Group Holdings Inc (SBC) | Healthcare | $300.6M | $173.6M | -15.5% | 29.4% | 19.4% | 7.5 | — |
| Phathom Pharmaceuticals, Inc. (PHAT) | Healthcare | $933.1M | $175.1M | 216.9% | — | — | — | — |
| Heartflow, Inc. (HTFL) | Healthcare | $2.09B | $176.0M | 39.9% | -66.3% | -38.8% | — | — |
| Cryoport, Inc. (CYRX) | Healthcare | $818.5M | $176.2M | 12.4% | 44.4% | 15.6% | 12.1 | — |
| Adaptimmune Therapeutics PLC (ADAPY) | Healthcare | $8.0M | $178.0M | 195.3% | -39.8% | -597.6% | — | — |
| Glass House Brands Inc. (GLAS) | Healthcare | $944.4M | $182.0M | -9.4% | -16.3% | — | — | — |
| Stoke Therapeutics, Inc. (STOK) | Healthcare | $1.85B | $184.4M | 404.5% | -3.7% | -2.0% | — | — |
| MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | Healthcare | $2.58B | $185.7M | -28.3% | -70.4% | -35.1% | — | — |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | Healthcare | $7.04B | $189.8M | 45.8% | — | — | — | — |
| biote Corp. (BTMD) | Healthcare | $89.6M | $192.2M | -2.5% | 14.1% | — | 5.7 | — |
| LAKELAND INDUSTRIES INC (LAKE) | Healthcare | $111.0M | $192.6M | 15.2% | -13.1% | -19.6% | — | — |
| LifeMD, Inc. (LFMD) | Healthcare | $187.6M | $194.1M | 25.3% | 7.4% | 62.0% | — | — |
| Strata Critical Medical, Inc. (SRTA) | Healthcare | $440.4M | $197.1M | 34.3% | 21.0% | 14.8% | 9.1 | — |
| SI-BONE, Inc. (SIBN) | Healthcare | $730.4M | $200.9M | 20.2% | -9.4% | -10.6% | — | — |
| Cytek Biosciences, Inc. (CTKB) | Healthcare | $590.2M | $201.5M | 0.5% | -33.0% | -19.5% | — | — |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | Healthcare | $2.76B | $211.1M | 27.1% | -24.2% | -216.9% | — | — |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | Healthcare | $262.7M | $212.7M | 1.6% | -27.7% | -67.6% | — | — |
| AMARIN CORP PLC\UK (AMRN) | Healthcare | $292.3M | $213.6M | -6.5% | -18.2% | -8.4% | — | — |
| Vanda Pharmaceuticals Inc. (VNDA) | Healthcare | $322.3M | $216.1M | 8.7% | — | -67.4% | — | — |
| IDEAYA Biosciences, Inc. (IDYA) | Healthcare | $3.37B | $218.7M | 3024.4% | -52.0% | -11.1% | — | — |
| Axogen, Inc. (AXGN) | Healthcare | $2.14B | $225.2M | 20.2% | -7.0% | -12.2% | — | — |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | Healthcare | $436.7M | $228.4M | -0.9% | 13.6% | 23.9% | 17.9 | — |
| Lifevantage Corp (LFVN) | Healthcare | $80.1M | $228.5M | 14.2% | 4.3% | 28.3% | 14.1 | 2.8% |
| Talkspace, Inc. (TALK) | Healthcare | $872.7M | $228.9M | 22.0% | 3.4% | 6.7% | — | — |
| CERUS CORP (CERS) | Healthcare | $627.2M | $233.8M | 16.1% | -6.7% | -24.1% | — | — |
| ANAPTYSBIO, INC (ANAB) | Healthcare | $1.72B | $234.6M | 157.0% | -5.6% | -35.6% | — | — |
| Akebia Therapeutics, Inc. (AKBA) | Healthcare | $359.5M | $236.2M | 47.5% | -2.3% | -16.4% | — | — |
| ORTHOPEDIATRICS CORP (KIDS) | Healthcare | $500.6M | $236.3M | 15.4% | -16.8% | -11.4% | — | — |
| Vaxart, Inc. (VXRT) | Healthcare | $121.0M | $237.3M | 726.7% | 6.9% | 18.6% | — | — |
Want more than a table?
Sign in to screen with custom filters (growth, ROIC, insider buying, short interest and 30+ more metrics), compare peers side by side, and get filing-grounded answers with citations. Free to start.
Start freeFundamentals from SEC EDGAR (public domain), as reported; valuation columns combine SEC filings with market data and are blanked where the two sources disagree. Informational only. Not investment advice.